6-Chloro-2-cyclopropyl-4-(trifluoromethyl)quinoline is a quinoline-based compound used as a pharmaceutical intermediate. It is specifically employed in the synthesis of Bcr-Abl tyrosine kinase inhibitors, which are a key class of therapeutics for chronic myelogenous leukemia.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 391860-73-4
Mirabegron (m16)
Pharmaceutical intermediate
2-Chloro-3,5-dinitrobenzotrifluoride
Pharmaceutical intermediate for synthesis
Tert-Butyl 3-(methylamino)piperidine-1-carboxylate
Pharmaceutical intermediate for API synthesis
N'-(2-cyano-4-nitrophenyl)-N,N-dimethylmethanimidamide
Pharmaceutical intermediate
6-chloro-2-cyclopropyl-4-(trifluoromethyl)quinoline
CXGFIHCGWHSIQO-UHFFFAOYSA-N
C1CC1C2=NC3=C(C=C(C=C3)Cl)C(=C2)C(F)(F)F